Medacta U

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Medacta U sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 1 completed upper quartile by trial count

Medacta U: 3 sponsored US clinical trials, 1 recruiting.

Medacta U sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Revision Hip Arthroplasty, with 1 trials.

Upper-quartile sponsor footprint

Medacta U sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

M-Vizion™ Macroscopic Radiographic Study

NCT05721859
ACTIVE NOT RECRUITING

Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

NCT03211663
COMPLETED

Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

NCT03897595

Therapeutic Areas

Revision Hip Arthroplasty 1
Knee Arthritis 1
Hip Osteoarthritis 1
Knee Pain Chronic 1
Knee Osteoarthritis 1

What is open in the Medacta U pipeline

1 recruiting of 3 indexed (33% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Revision Hip Arthroplasty (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medacta U: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Medacta U sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Medacta U10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Medacta U sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medacta U sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Medacta U page

3 registered trials is a research-attention snapshot, not an endorsement of Medacta U or any single study.

  • 1 of Medacta U's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Revision Hip Arthroplasty is the condition Medacta U studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Revision Hip Arthroplasty trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Medacta U pipeline card: 3 registered trials from official public datasets.Report a data error.